Biliary disease and cholecystectomy after initiation of elexacaftor/ivacaftor/tezacaftor in adults with cystic fibrosis.

[1]  D. Kleiner,et al.  Hepatic Manifestations of Cystic Fibrosis. , 2019, Clinics in liver disease.

[2]  D. Assis,et al.  Gallbladder and bile duct disease in Cystic Fibrosis. , 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[3]  P. Durie,et al.  Cystic fibrosis from the gastroenterologist's perspective , 2016, Nature Reviews Gastroenterology &Hepatology.

[4]  G. Magazzù,et al.  Postoperative Outcomes and Quality of Life in Patients With Cystic Fibrosis Undergoing Laparoscopic Cholecystectomy: A Retrospective Study , 2011, Surgical laparoscopy, endoscopy & percutaneous techniques.

[5]  W. Balistreri,et al.  Hepatobiliary disease in patients with cystic fibrosis , 2009, Current opinion in gastroenterology.

[6]  M. Curry,et al.  The gallbladder and biliary tract in cystic fibrosis , 2005, Current gastroenterology reports.

[7]  M. Strazzabosco,et al.  Liver and biliary problems in cystic fibrosis. , 1998, Seminars in liver disease.

[8]  W. Kirwan,et al.  Laparoscopic cholecystectomy in adult cystic fibrosis , 1997, Irish journal of medical science.

[9]  F. Collins,et al.  Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. , 1993, Gastroenterology.

[10]  W. Warwick,et al.  Operative therapy of gallbladder disease in patients with cystic fibrosis. , 1989, American journal of surgery.

[11]  R. Stern,et al.  Treatment and Prognosis of Symptomatic Gallbladder Disease in Patients with Cystic Fibrosis , 1986, Journal of pediatric gastroenterology and nutrition.